col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: SCEEMP
  original article Journal Date Title Authors All Authors
1 [GO] BIOpreparations Prevention Diagnosis Treatment 2021―Oct―04 Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit D. A. Poteryaev, S. G. Abbasova, P. E. Ignatyeva, O. M. Strizhakova, S. V. Kolesnik, R. A. Khamitov
2 [GO] BIOpreparations Prevention Diagnosis Treatment 2021―Oct―04 Comparative characteristics of COVID-19 vaccines used for mass immunisation G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich
3 [GO] The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2021―Mar―10 Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic D. P. Romodanovsky, A. L. Khokhlov, D. V. Goryachev
4 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Dec―15 Analysis of Promising Approaches to COVID-19 Vaccine Development G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich
5 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Dec―15 Russian and International Regulatory Recommendations for the Development and Marketing Authorisation of COVID-19 Vaccines in the Context of the Pandemic A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. A. Merkulov, V. D. Mosyagin, V. B. Ivanov, et al. (+2)
6 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Sep―18 Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19 D. A. Poteryaev, R. A. Khamitov, G. A. Efimov, A. M. Shuster
7 [GO] The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2020―Sep―18 Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19 B. K. Romanov
8 [GO] Safety and Risk of Pharmacotherapy 2020―Sep―18 Safety of Remdesivir and Tocilizumab in COVID-19 Treatment Article Editorial
9 [GO] Safety and Risk of Pharmacotherapy 2020―Mar―28 Coronavirus disease COVID-2019 B. K. Romanov
10 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Mar―26 An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare D. V. Gorenkov, L. M. Khantimirova, V. A. Shevtsov, A. V. Rukavishnikov, V. A. Merkulov, Yu. V. Olefir


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.007 sec